Introduction
coronary heart disease, arrhythmia, cardiovascular adverse
HEART, CORONARY HEART DISEASE, ATRIAL FIBRILLATION (AF), ARRHYTHMIA
Atrial fibrillation (AF) is the most common arrhythmia. Based on data from the Framingham Heart Study (FHS), the prevalence of AF has increased three-fold over the last 50 years.A new oral hypoglycaemic drug, dapagliflozin, a sodium-glucose cotransporter-2 inhibitor (SGLT2i), was confirmed to reduce the risk of cardiovascular adverse events (AEs) and improve coronary heart disease and HF outcomes in multiple clinical trials.